Jörg Sellmann

Jörg Sellmann is one of the managing directors of DEMECAN since 2021 and responsible for the finance division, including fundraising and M&A.

DEMECAN was founded in 2017 is the only independent producer of medical cannabis. The company works on behalf of the German Federal Institute for Drugs and Medical Devices (BfArM).

After an apprenticeship as a banker at Deutsche Bank, Jörg Sellmann completed a degree in business administration at the Westfälische Wilhelms University in Münster. Before joining DEMECAN’s management team, he worked in investment banking for several years before holding the position of Global Head of M&A at the chemical group Degussa AG in Düsseldorf. Subsequently, Sellmann was Senior Director at the European private equity fund EQT in Munich. After his work at EQT, he successfully founded start-ups in various sectors, has since been active as a business angel and is also a shareholder of DEMECAN.